Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
sein des génomes de souches de E. coli isolées de patients atteints de MC. Leur prévalence dans les génomes de souches AIEC de même que leur rôle dans l'invasion épithéliale par ces souches restent à
-
-immobilized whole-cell biocatalysts based on viable recombinant E. coli cells for the production of chemical specialties. The cascade of three redox enzymes co-expressed in E. coli bacteria as
-
ingénierie des protéinesCountryFranceCityMARSEILLE 09Geofield Contact City MARSEILLE 09 Website http://bip.cnrs-mrs.fr STATUS: EXPIRED X (formerly Twitter) Facebook LinkedIn Whatsapp More share options E-mail
-
/sites/synhg/ and Zürcher et al. 2023 Continuous synthesis of E. coli genome sections and Mb-scale human DNA assembly Nature 619, 555 – 562. (https://www.nature.com/articles/s41586-023-06268-1). You should
-
selection of aptamers for Shiga-like toxins of E. coli and determination of their affinity; Evaluation of aptamer libraries, based on data generated by sequencing; Application of bioinformatics tools
-
Sorbonne Université SIS (Sciences, Ingénierie, Santé) | Paris 15, le de France | France | 9 days ago
a lieu une fois par cycle cellulaire. Chez Escherichia coli, ce processus est étroitement lié à la masse cellulaire, de sorte qu'au moment de l'initiation, le rapport entre l'origine et la masse est
-
the repeated sequence in E. coli, and studying its binding to calcium and potassium using NMR, rheometry and spectrometry, as well as modelling it using molecular dynamics. The study aims to create a model for
-
Website https://www.iniav.pt Street Quinta do Marquês, Av. da República Postal Code 2784505 STATUS: EXPIRED X (formerly Twitter) Facebook LinkedIn Whatsapp More share options E-mail Pocket Viadeo Gmail
-
working with diverse host organisms (e.g., E. coli, yeast, mammalian cells) is a significant plus. Deep expertise in advanced genome engineering tools (e.g., CRISPR/Cas systems, base editing, prime editing
-
therapeutic drug target against tuberculosis, using potential inhibitors from different families of metallic and non-metallic compounds. The work plan includes: PtpA production – Expression (E. coli BL21) and